1. ERAP1-IN-4

ERAP1-IN-4 是一种口服有效的内质网氨肽酶 1 (ERAP1) 抑制剂。ERAP1-IN-4 可抑制 ERAP1 对肽底物的水解作用,对 Allotype1Allotype2 活性较强,对其他同种异型的效力降低。ERAP1-IN-4 可调控 ERAP1 介导的肽加工过程,从而抑制抗原表位呈递。ERAP1-IN-4 可用于癌症研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

ERAP1-IN-4

ERAP1-IN-4 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

ERAP1-IN-4 is an orally acvtive endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitor. ERAP1-IN-4 inhibits hydrolysis of peptide substrates by ERAP1, with high activity against Allotype1 and Allotype2. ERAP1-IN-4 reduced efficacy against other allotypes, and modulates ERAP1-mediated peptide processing to inhibit antigenic epitope presentation. ERAP1-IN-4 can be used for the research of cancer[1].

体外研究
(In Vitro)

ERAP1-IN-4 (Compound 40) 可强效抑制 ERAP1 同种异型 2 的酶活性,其 pIC50 为 7.9,LLE 为 5.3[1]
ERAP1-IN-4 可抑制 HeLa 细胞中的抗原呈递,测得的 pIC50 为 7.3,未结合细胞的 pIC50 为 7.8[1]
ERAP1-IN-4 (0.5-5 μM;4 小时) 在大鼠血液中的游离分数为 0.04,在人肝微粒体中的游离分数为 0.83[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

药代动力学
(Parmacokinetics)
Species Dose Route CL T1/2 Vdss F AUC0-t Cmax
Rat[1] 1 mg/kg i.v. 29 mL/min/kg 7.1 h 5.0 L/kg / / /
Rat[1] 2 mg/kg p.o. / / / 47 % 272 ng·h/mL 22 ng/mL
体内研究
(In Vivo)

ERAP1-IN-4 (Compound 40) (1-3 mg/kg;静脉注射或口服) 在健康大鼠中表现出 47%的口服生物利用度,在 3 mg/kg 口服剂量下的游离口服 AUC0-t,u 为 10.9 ng·h/mL[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Wistar Han[1]
Dosage: 1 mg/kg (i.v.); 3 mg/kg (p.o.)
Administration: i.v. or p.o.
Result: Exhibited unbound clearance (CLu) of 725 mL/min/kg, half-life (t1/2) of 7.1 h, and unbound volume of distribution at steady state (Vd,ss,u) of 125 L/kg following intravenous dosing at 1 mg/kg.
Achieved oral bioavailability (F%) of 47%, dose-normalized unbound area under the curve (AUCt,u) of 10.9 ng·h/mL, and dose-normalized unbound peak concentration (Cmax,u) of 0.87 ng/mL following oral dosing at 3 mg/kg.
分子量

467.26

Formula

C16H14BrF3N2O4S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

ERAP1-IN-4 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
ERAP1-IN-4
目录号:
HY-183267
需求量: